BorisPascheMDPhD, FACP

Gastrointestinal Cancer, Hematologic Oncology

President & CEO, Karmanos Cancer Institute; Chair, Department of Oncology, Wayne State University; Comprehensive Cancer Center

Dr. Pasche is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1994 - 2000
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1992 - 1994
Harvard Medical SchoolPost-Doctoral Fellowship, 1989 - 1992
University of LausanneM.D., 1980 - 1987
Karolinska Institute Faculty of MedicineClass of 1986

America's Top Doctors Castle Connolly, 2010-2022
America's Top Doctors for Cancer Castle Connolly, 2009-2022
Elected Member The American Clinical and Climatological Association (ACCA), 2014
Jeannik M . Littlefield-AACR Award in Metastatic Colon Cancer Research AACR, 2006
The Ohio State University Human Cancer Genetics Program Commemorative Medal Ohio State University, 2005
Elected Fellow The American College of Physicians-The American Society of Internal Medicine, 2004
Traineed Investigator Award for Excellence in Scientific Research American Society for Clinical Investigation, 1992
Young Scientist Merit Award The International Society on Thrombosis and Hemostasis, 1989, 1991
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Elected Member The American Society for Clinical Investigation, 2007
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

PubMed

153 citations
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Xiangchun Li, Boris Pasche, Wei Zhang, Kexin Chen
JAMA Oncology. 2018-12-01
113 citations
Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis.
Zhen Cai, Chien Feng Li, Fei Han, Chunfang Liu, Anmei Zhang
Molecular Cell. 2020-10-15
82 citations
Cancer cell proliferation is inhibited by specific modulation frequencies.
Jacquelyn W. Zimmerman, Michael J. Pennison, Ivan A. Brezovich, Nengjun Yi, Celeste T. Yang
British Journal of Cancer. 2012-01-17

Journal Articles

Association of MUC16 Mutation with Tumor Mutation Load and Outcomes in Patients with Gastric Cancer
Boris Pasche, MD, JAMA

Boris C. Pasche named president & CEO of Karmanos, chair of Wayne State Department of OncologyAugust 11th, 2023
Barbara Ann Karmanos Cancer Institute, Wayne State University Name New CEOAugust 7th, 2023
Oncologists on the MoveMarch 8th, 2022
Join now to see all

TGFBR1 Signaling In Colorectal CancerNational Cancer Institute2010–2012
Role Of Tgf-Beta Genetic Variants In The Pathogenesis Of SclerodermaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
Tgf-Beta Polymorphisms And Breast Cancer In FamiliesNational Cancer Institute2009–2011
Role Of Tgf-Beta Genetic Variants In The Pathogenesis Of SclerodermaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2010
Tgf-Beta Pathway Variants And Breast Cancer In FamiliesNational Cancer Institute2008
Tgf-Beta Pathway Polymorphisms And Colon Cancer RiskNational Cancer Institute2008
Tgf-Beta Pathway Polymorphisms And Colon Cancer RiskNational Cancer Institute2006–2008
Tgf-Beta Pathway Variants And Breast Cancer In FamiliesNational Cancer Institute2005–2008
Mutations Of The Type 1 TGF Beta Receptor In CancerNational Cancer Institute2001–2002
Type 1 TGF Beta Receptor AlterationsNational Cancer Institute2000–2001
Type 1 TGF Beta Receptor AlterationsNational Cancer Institute1999–2000
Comprehensive Cancer Center Core Support GrantNational Cancer InstitutePresent